People Background Check
Find People:

Leah ByrneSan Francisco, CA

Get Report

Leah Byrne Phones & Addresses

San Francisco, CA

460A Waller St, San Francisco, CA 94117

Social networks

Leah Byrne

Linkedin

Work

Company: Chevy chase trust Aug 2007 Position: Vice president

Education

School / High School: Georgetown University 2012 to 2013

Ranks

Certificate: Certified Financial Planner™ Certification

Industries

Investment Management

Mentions for Leah Byrne

Leah Byrne resumes & CV records

Resumes

Leah Byrne Photo 31

Vice President

Location:
Bethesda, MD
Industry:
Investment Management
Work:
Chevy Chase Trust
Vice President Wells Fargo May 2006 - Apr 2007
Loan Officer and Credit Analyst Ubs Jun 2005 - Apr 2006
Intern
Education:
Georgetown University 2012 - 2013
The University of Alabama 2001 - 2005
Bachelors, Bachelor of Science, Finance
Certifications:
Certified Financial Planner™ Certification

Publications & IP owners

Us Patents

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2022033, Oct 20, 2022
Filed:
Jun 16, 2022
Appl. No.:
17/842553
Inventors:
- Oakland CA, US
- Philadelphia PA, US
William A. Beltran - Philadelphia PA, US
Leah C. Byrne - San Francisco CA, US
Meike Visel - El Cerrito CA, US
International Classification:
A61K 48/00
A61K 9/00
C12N 7/00
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2022033, Oct 20, 2022
Filed:
Jun 16, 2022
Appl. No.:
17/842639
Inventors:
- Oakland CA, US
- Philadelphia PA, US
William A. Beltran - Philadelphia PA, US
Leah C. Byrne - San Francisco CA, US
Meike Visel - El Cerrito CA, US
International Classification:
A61K 48/00
A61K 9/00
C12N 7/00
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2022024, Aug 4, 2022
Filed:
Dec 14, 2021
Appl. No.:
17/551030
Inventors:
- Oakland CA, US
Ryan R. KLIMCZAK - San Francisco CA, US
James T. KOERBER - San Mateo CA, US
John G. FLANNERY - Berkeley CA, US
Deniz DALKARA MOUROT - Berkeley CA, US
Meike Visel - El Cerrito CA, US
Leah C.T. BYRNE - Berkeley CA, US
International Classification:
C12Q 1/70
A61K 48/00
C07K 14/005
C12N 15/86
C12N 7/00
G01N 33/50
A61K 9/00
A61K 38/17
C12N 15/113
C12N 15/115
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2022036, Nov 17, 2022
Filed:
Jun 16, 2022
Appl. No.:
17/842530
Inventors:
- Oakland CA, US
- Philadelphia PA, US
William A. Beltran - Philadelphia PA, US
Leah C. Byrne - San Francisco CA, US
Meike Visel - El Cerrito CA, US
International Classification:
A61K 48/00
A61K 9/00
C12N 7/00
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2021028, Sep 16, 2021
Filed:
Jul 27, 2017
Appl. No.:
16/315032
Inventors:
- Oakland CA, US
- Phladelphia PA, US
William A. Beltran - Philadelphia PA, US
Leah C. Byrne - San Francisco CA, US
Meike Visel - El Cerrito CA, US
International Classification:
A61K 48/00
C12N 7/00
A61K 9/00
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsids And Methods Of Use Thereof

US Patent:
2020012, Apr 23, 2020
Filed:
Jun 28, 2018
Appl. No.:
16/486681
Inventors:
- Oakland CA, US
Leah C. Byrne - San Francisco CA, US
Timothy P. Day - Berkeley CA, US
John G. Flannery - Berkeley CA, US
International Classification:
A61K 35/761
A61K 48/00
A61P 27/02
C12N 15/113
C12N 15/86
C07K 14/075
C12N 9/22
C12N 15/90
A61K 9/00
Abstract:
The present disclosure provides recombinant adeno-associated virus (AAV) virions with altered capsid protein, where the recombinant AAV (rAAV) virions exhibit greater ability to cross barriers between intravitreal fluid and retinal cells, and thus greater infectivity of a retinal cell compared to wild-type AAV, and where the rAAV virions comprise a heterologous nucleic acid. The present disclosure provides methods of delivering a gene product to a retinal cell in an individual.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2019021, Jul 18, 2019
Filed:
Dec 21, 2018
Appl. No.:
16/230080
Inventors:
- Oakland CA, US
Ryan R. Klimczak - San Francisco CA, US
James T. Koerber - San Francisco CA, US
John G. Flannery - Berkeley CA, US
Deniz Dalkara Mourot - Berkeley CA, US
Meike Visel - El Cerrito CA, US
Leah C.T. Byrne - Berkeley CA, US
International Classification:
C12Q 1/70
C12N 15/113
A61K 48/00
C07K 14/005
C12N 15/86
C12N 7/00
G01N 33/50
A61K 9/00
A61K 38/17
C12N 15/115
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Adeno-Associated Virus Virions With Variant Capsid And Methods Of Use Thereof

US Patent:
2016037, Dec 29, 2016
Filed:
Aug 23, 2016
Appl. No.:
15/244892
Inventors:
- Oakland CA, US
Ryan R. Klimczak - San Francisco CA, US
James T. Koerber - San Francisco CA, US
John G. Flannery - Berkeley CA, US
Deniz Dalkara Mourot - Berkeley CA, US
Meike Visel - El Cerrito CA, US
Leah C.T. Byrne - Berkeley CA, US
International Classification:
A61K 48/00
C07K 14/005
A61K 9/00
C12N 7/00
Abstract:
The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.

Possible Relatives

David R Byrne  Deanna S Byrne  Dale W Byrne  Aaron M Byrne  Deirdre A Byrne  Danielle K Byrne  Dennis J Byrne  Leah L Johnston  Leah R Jones  Leah K Stanley 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.